News

Continuous glucose monitoring devices could overstate blood sugar levels, with a study revealing inconsistencies in readings compared with traditional methods.
The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with ...
The following is a summary of “Evidence for improved glucose metrics and perinatal outcomes with continuous glucose ...
In addition to improved accuracy, the Dexcom G7 15 Day allows for 15.5 days of wear. The Food and Drug Administration (FDA) has cleared the Dexcom G7 15 Day continuous glucose monitoring (CGM ...
Two endocrinologists who live with type 1 diabetes debate this issue at the Advanced Technologies & Treatments for Diabetes ...
As part of the provincial government’s ... which can cause complications and potentially be fatal. Select continuous glucose monitoring systems, such as Dexcom G7 and Dexcom G6, are equipped ...
Credit: Dexcom. The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.
Unlike traditional continuous glucose monitors that measure glucose levels in interstitial ... Information on the Company’s website does not constitute a part of and is not incorporated by reference ...
1 Continuous glucose monitors (CGMs) are revealing surprising ... she explored the origins and diversification of blindsnakes in India, as a part of which she did extensive fieldwork in the ...
Among patients with type-2 diabetes (T2D) requiring insulin therapy, automated insulin delivery (AID) resulted in a greater ...
RUTHERFORD, N.J. and STOCKHOLM, April 03, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel ...